Low-molecular-weight heparin for the treatment of venous thromboembolism
- 1 June 1998
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 135 (6) , S336-S342
- https://doi.org/10.1053/hj.1998.v135.90303
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and SafetyChest, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4Blood, 1994
- HeparinNew England Journal of Medicine, 1991
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172Blood, 1989
- Binding and endocytosis of heparin by human endothelial cells in cultureBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1985
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- Factor‐Xa Inactivation by Antithrombin IIIBritish Journal of Haematology, 1973